MorphiDex® (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: Three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance

Caruso, 2000, MorphiDex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain., J Pain Symptom Manage, 19, S31, 10.1016/S0885-3924(99)00128-1 Chevlen, 2000, Morphine with dextromethorphan: conversion from other opioid analgesics., J Pain Symptom Manage, 19, S42, 10.1016/S0885-3924(99)00130-X Grass, 1996, N-methyl-D-aspartate receptor antagonists potentiate morphines antinociceptive effect in the rat., Acta Physiol Scand, 158, 269, 10.1046/j.1365-201X.1996.566309000.x Jansinski, 2000, Abuse potential of morphinedextromethorphan combinations., J Pain Symptom Manage, 19, S26, 10.1016/S0885-3924(99)00127-X Katz, 2000, MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients., J Pain Symptom Manage, 19, S37, 10.1016/S0885-3924(99)00129-3 Mao, 1995, Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions., Pain, 62, 259, 10.1016/0304-3959(95)00073-2 Mao, 1996, Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats., Pain, 67, 361, 10.1016/0304-3959(96)03120-X Petrenko, 2003, The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review., Anesth Analg, 97, 1108, 10.1213/01.ANE.0000081061.12235.55 Price, 2000, NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance., J Pain Symptom Manage, 19, S7, 10.1016/S0885-3924(99)00121-9